The U.S. Food and Drug Administration (FDA) is kicking off a webinar series on the topic of Respirators for Health Care Personnel Use during COVID-19 Pandemic. During this webinar, the FDA will share information and answer questions about emergency use authorizations (EUAs) for respirators, importing respirators, and overall FDA actions to help assure health care personnel on the front lines have the necessary supplies of respirators to meet the demand.
Respirators are a type of personal protective equipment (PPE) that are used to protect the wearer from airborne particles and from liquid contaminating the face. Personal protective equipment (PPE) is designed to protect the wearer from injury or help prevent wearer exposure to infection or illness.
The FDA continues to actively monitor and help mitigate any potential shortages in the supply chain, including the medical device supply chain. This includes taking action to help assure health care personnel on the front lines have the necessary supplies of personal protective equipment to meet the demand.
We encourage all interested stakeholders to join the webinar. Registration is not necessary.
Hear from speakers, including:
* Stephen M. Hahn MD, Commissioner of Food and Drugs at the FDA
* Jeffrey E. Shuren MD, JD, Director of the Center for Devices and Radiological Health (CDRH) at the FDA
* William H. Maisel, MD, MPH, Director, Office of Product Evaluation and Quality (OPEQ) at CDRH
* Suzanne Schwartz, MD, MBA, Director, Office of Strategic Partnerships and Technology Innovation (OST) at CDRH